Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Genitourinary Cancers
•
Prostate Cancer
•
Medical Oncology
How many cycles of docetaxel do you give to patients with metastatic castration resistant prostate cancer?
Answer from: Medical Oncologist at Community Practice
Toxicity with Neuropathy can be a major problem in the elderly population.
Sign in or Register to read more
5102
Related Questions
Why is there a benefit of ADT for high risk prostate cancer treated with radiation, yet no large trials describing benefit of adjuvant ADT after radical prostatectomy?
Do you add ADT to RT for a patient with intermediate-risk prostate cancer with discordant Decipher and ArteraAI results?
In which patients are referring for focal gland therapy for localized prostate cancer?
What is your experience with Pylarify vs. Posluma PSMA PET for prostate cancer and is one preferred over the other?
For a patient post-prostatectomy with a high PSA (>1), a negative MRI pelvis, and a negative PSMA PET scan, do you pursue any other imaging?
What data support the use of continuing GnRH therapy "backbone" in metastatic castration resistant prostate cancer (mCRPC) receiving additional therapies?
Which patients, if any, do you offer transdermal estradiol as a method of ADT instead of LHRH agonists?
When do you start ADT for a patient with a new diagnosis of node positive prostate cancer receiving radiation?
Would you prescribe semaglutide for weight gain from androgen deprivation therapy for prostate cancer?
Is there any evidence that ivermectin suppresses the PSA level in prostate cancer?